What we are particularly good at – our main focal points
The Schüchtermann-Klinik specialises in cardiovascular diseases. By focusing on this field, we can direct all of our efforts towards being a leader in both the quality of the treatment and in terms of our knowledge and skills. In our closely networked specialist departments we look after patients during the various stages of their disease.
The concept of the clinic with the specialist medical departments of cardiology, cardiac surgery, anaesthesiology and rehabilitation enables the seamless provision of health care to patients without changing clinics or suffering long waiting times. This continuity of medical, nursing and therapeutic care accelerates the recovery process and shortens the length of time patients spend in hospital. On the basis of our many years of experience and specialisation, we are able to offer our patients excellent quality of care.
As an integrated cardiac centre, we offer all options for the diagnosis and treatment of congenital and acquired diseases of the heart and blood vessels during adulthood.
DIAGNOSTIC AND TREATMENT OPTIONS
- cute healthcare in the intensive care and monitoring units
- cardiac catheter and vascular diagnostics in five examination rooms
- catherisation on the heart (PTCA), the arteries of the legs (PTA), as well as the renal and cerebral arteries
- major cardiac surgery in five operating theatres
- combined interventions in a hybrid operating theatre
- post-operative care on five acute care wards
- and subsequent rehabilitation on four rehabilitation ward
In spite of the wide range of services we offer, there are certainly some particular aspects of the Schüchtermann-Klinik which distinguish us from other clinics:
WORKING TOGETHER IN THE CARDIAC TEAM
One particular focus of the Schüchtermann-Klinik is the close cooperation within the cardiac team. For several years we have been performing hybrid interventions, i.e. the combination of cardiac surgery and cardiological interventions. As a result of the establishment of a hybrid operating theatre in 2010, optimum framework conditions were created for joint treatment by cardiologists, cardiac surgeons and anaesthetists. Further information on our interdisciplinary cooperation can be found HERE.
TREATMENT OF VALVULAR HEART DISEASE
Since 2008 the Schüchtermann-Klinik has been one of the leading centres for catheter-based treatments of heart valve diseases. With more than 700 minimally invasive aortic valve interventions over the last six years it has also been possible to treat patients who could not be considered for an operation using a heart-lung machine due to the excessive risk.
In addition to this aortic valve replacement (TAVI), during which the patient’s chest does not need to be opened, catheter-based mitral valve reconstructions have also been carried out since 2010 at the Schüchtermann-Klinik using the MitraClip® system. This procedure supplements drug or cardiosurgical treatment as a third, particularly gentle treatment option.
The catheter-based procedure is performed in the hybrid operating theatre on the beating heart; in most cases the patient can be discharged just a few days after the surgery. Over the last three years approximately 130 interventions on the mitral valve have been performed, as a result of which this interventional procedure has taken on an important role in the treatment of mitral regurgitation.
Nevertheless, invasive treatments of valvular heart disease also form part of the range of our surgical procedures. These include not only heart valve reconstruction, but also biological or mechanical cardiac valve replacement.
VENTRICULAR ASSIST DEVICES
Unlike almost any other disease, the severe form of heart failure (cardiac insufficiency) represents a significant burden in the daily lives of those affected. Their joie de vivre and quality of life suffer greatly as a rule due to the slow but steady decrease in the pumping ability of the heart.
If a patient experiences shortness of breath even at rest, a heart transplant must be considered. Suitable donor organs are only rarely available at short notice, so that mechanical circulatory support (VAD) is playing an increasingly important role in either bridging the time until a transplant or as a permanent therapy.
The transplantation of these mechanical cardiac support systems and the subsequent rehabilitation of patients have become main focal points of our work over the last few years. When all conventional therapeutic measures have been exhausted, mechanical circulatory support has become largely established for the treatment of advanced chronic heart failure. Our patients benefit from the so-called artificial heart systems, in which the mortality rate is significantly lowered with a considerable simultaneous improvement in quality of life.